Treatment of may⇔thurner syndrome with catheter-directed thrombolysis and stent placement, complicated by heparin-induced thrombocytopenia

Vascular

Volumn 6, Issue 6, 1998, Pages 607-613

  Seidensticker, D ^a   Wilcox, J ^a   Gagne, P ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

heparin; iliofemoral; May Thurner syndrome; thrombocytopenia; thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANCROD; ANTITHROMBOCYTIC AGENT; DANAPAROID; DEXTRAN 40; HEPARIN; HEPARINOID; STREPTOKINASE; UROKINASE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; ECHOGRAPHY; FEMALE; FEMORAL VEIN; FIBRINOLYTIC THERAPY; HUMAN; ILIAC VEIN; INTRAVENOUS DRUG ADMINISTRATION; LEG EDEMA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; THROMBOCYTOPENIA;

ADULT; ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; DIAGNOSTIC IMAGING; FEMALE; FEMORAL VEIN; HEPARIN; HUMANS; ILIAC ARTERY; ILIAC VEIN; LYMPHEDEMA; PULMONARY EMBOLISM; STENTS; SYNDROME; THROMBOCYTOPENIA; THROMBOLYTIC THERAPY; THROMBOSIS; URINARY PLASMINOGEN ACTIVATOR; WARFARIN;

EID: 0032439185     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099800600613     Document Type: Article

References (29)

1. O'Donnell T. F., Browse N. L., Burnand K. G., Thomas M. L., The socioeconomic effects of an iliofemoral thrombosis. Journal of Surgical Research, 1987, 22, 483–488.
2. May R., Thurner J., The case of the predominantly left-sided occurrence of thrombosis of the pelvic veins. Argiology, 1957, 8, 419–427.
3. Ferris E. J., Lim W. N., Smith P. L., Casali R., May—Thurner syndrome. Radiology, 1983, 147, 29–31.
4. Steinberg J. B., Jacocks M. A., May—Thurner syndrome: A previously unreported variant. Annals of Vascular Surgery, 1993, 7, 577–581.
5. Strandness R. E., Lanlois Y. E., Cramer M., et al, Long term sequelae of acute venous thrombosis. Journal of the American Medical Association, 1983, 250, 1289–1292.
6. Markel A., Manzo R. A., Bergeliin B. S., Strandness D. E., Valvular reflux after deep vein thrombosis: Incidence and time of occurrence. Journal of Vascular Surgery, 1992, 15, 377–383.
7. Meissner A. J., Huszcza S., Surgical strategy for management of deep venous thrombosis of the lower extremities. World Journal of Surgery, 1996, 20, 1149–1155.
8. Comerota A. J., Venous thromboembolism. In Vascular Surgery, vol 2, ed. Rutherford R. B., W. B. Saunders Co., Philadelphia, 1995, pp. 1785–1814.
9. Eklof B., Kistner R. L., Is there a role for thrombectomy in iliofemoral venous thrombosis? Seminars in Vascular Surgery, 1996, 9, 34–45.
10. Comerota A. J., Thrombolytic therapy for acute deep vein thrombosis. In Thrombolytic Therapy for Peripheral Vascular Disease. J. B. Lipppincott Co., Philadelphia, 1995, pp. 175–195.
11. Strandness E. D., Manzo R. A., Markel A., Is there a role for thrombolytic treatment of deep vein thrombosis? Cardiology Board Review, 1993, 10, 25–27.
12. Sherry S., Thrombolytic therapy for DVT. Seminars in Interventive Radiology, 1985, 2, 331–337.
13. Semba C. P., Dake M. D., Catheter-directed thrombolysis for iliofemoral venous thrombosis. Seminars in Vascular Surgery, 1996, 9, 30.
14. Graor R. A., Young J. R., Risius G., Ruschhaupt W. F., Comparison of cost effectiveness of streptokinase and urokinase in the treatment of deep venous thrombosis. Annals of Vascular Surgery, 1987, 1, 524–528.
15. Semba C. P., Dake M. D., Catheter-directed thrombolysis for iliofemoral venous thrombosis. Seminars in Vascular Surgery, 1996, 9, 31–33.
16. Zollikofer C. L., Antonucci F., Stuckmann G., et al, Use of the Wallstent in the venous system including hemodialysis-related stenoses. Cardiovascular and Interventional Radiology, 1992, 15, 334–341.
17. Juhan C. M., Alimi Y. S., Barthelemy P. J., et al, Late results of iliofemoral venous thrombectomy. Journal of Vascular Surgery, 1997, 25, 417–422.
18. Chong B. H., Heparin-induced thrombocytopenia. British Journal of Heamotology, 1995, 89, 431–439.
19. Blauhut B., Kramar H., Vinazzer H., Bermann H., Substitution of antithrombin III in shock and DIC: A randomized study. Thrombosis Research, 1985, 39, 81–89.
20. Visentin G. P., Ford S. E., Aster R. H., Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound endothelial cells. Journal of Clinical Investigation, 1994, 93, 81–88.
21. Greinacher A., Amiral J., Dummel V., et al, Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme linked immunosorbent assay. Transfusion, 1994, 34, 381–385.
22. Jackson M. R., Krishnamurti C., Aylesworth C. A., Alving B. M., Diagnosis of heparin-induced thrombocytopenia in the vascular surgery patient. Surgery, 1997, 121, 419–424.
23. Arepally G., Reynolds C., Tomaski A., et al, Comparison of PF4/Heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. American Journal of Clinical Pathology, 1995, 104, 648–654.
24. Warkentin T. E., Levine M. N., Hirsh J., Horsewood P., et al, Heparin induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. New England Journal of Medicine, 1995, 332(20), 1330–1335.
25. Magnani H. N., Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172). Thrombosis and Haemostasis, 1993, 70, 554–561.
26. Krishnamurti C., Bolan C. D., Reid T. J., Alving B. M., Pharmacology and mechanism of action of Ancrod: Potential for inducing thrombosis. Blood, 1992, 79, 2492.
27. Demers C., Ginsber J. S., Brill-Edwards P., et al, Rapid anticoagulation using Ancrod for heparin-induced thrombocytopenia. Blood, 1991, 78, 2194–2197.
28. Sobel M., Adelman B., Greenfield L. J., Dextran 40 reduces heparin-mediated platelet aggregation. Journal of Surgical Research, 1986, 40, 382–387.
29. Suzuki K., Hashimoto S., Effect of dextran sulphates on thrombin activity. Journal of Clinical Pathology, 1979, 32, 439–444.